Erudio Healtherudio.com
Sponsor
Gustave Roussy, Cancer Campus, Grand Paris trials: what clinicians said in public
An HCP commentary report on 1 clinical trial sponsored by Gustave Roussy, Cancer Campus, Grand Paris: ICARUS-LUNG01. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source. Below them, 3 more trials with public commentary and no report yet.
Listed by lead sponsor as registered on ClinicalTrials.gov (Gustave Roussy, Cancer Campus, Grand Paris). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| ICARUS-LUNG01 NCT04940325 · Gustave Roussy, Cancer Campus, Grand Paris | advanced and/or unresectable non-small cell lung cancer | Phase 2 | 59 | 25 | Focused | Oct 31, 2026 | Preview |
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| Lung ART NCT00410683 · Gustave Roussy, Cancer Campus, Grand Paris DeepView → | completely resected non-small-cell lung cancer with N2 involvement | Phase 3 | Deep | View | |||
| CARE1 NCT06364631 · Gustave Roussy, Cancer Campus, Grand Paris DeepView → | first-line metastatic renal cell carcinoma | Phase 3 | Deep | View | |||
| PANDORE NCT03212651 · Gustave Roussy, Cancer Campus, Grand Paris FocusedView → | muscle-invasive bladder cancer | Phase 2 | Focused | View | |||